Cite
HARVARD Citation
Zoulim, F. et al. (2020). Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial. Human vaccines & immunotherapeutics. 16 (2), pp. 388-399. [Online].